Iconic Labs PLC Conversion of Securities (8617T)
17 Noviembre 2023 - 5:32AM
UK Regulatory
TIDMICON
RNS Number : 8617T
Iconic Labs PLC
17 November 2023
Iconic Labs PLC
("Iconic" or the "Company")
Conversion of Notes and Allotment of Shares
Iconic Labs PLC (LSE:ICON), announces that it has received a
valid Conversion Notice from the Linton Capital LLP ("Linton").
The Conversion Notice was dated 16 November 2023 and provides
for 2 Convertible Notes to be converted into 100,000 ordinary
shares of GBP0.1 in the Company ("Ordinary Shares") at a conversion
price of GBP0.1 at the aggregate principal amount of GBP10,000.
The Conversion Notice also included a Conversion Fee, payable
under the financing arrangements with Linton, in the event that the
price at 90% of the Lowest Closing Volume-Weighted Average Price
during the applicable pricing period falls below the nominal value
of the Ordinary Shares. The Conversion Fee has been satisfied by
the issue to Linton of an additional 119,731 Ordinary Shares.
Application is therefore being made for an aggregate of 219,731
new Ordinary Shares to be admitted to trading on the Main Market of
the London Stock Exchange which is expected to be on or around 24
November 2023. These shares rank pari passu with the existing
Ordinary Shares of the Company.
Following the issue of these shares, the Company's issued
ordinary share capital shall consist of 8,371,600 Ordinary Shares.
The figure of 8,371,600 represents the total voting rights in the
Company and should be used by shareholders as the denominator for
the calculation by which they can determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure Guidance
& Transparency Rules.
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with
the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CONEAFFXFASDFFA
(END) Dow Jones Newswires
November 17, 2023 06:32 ET (11:32 GMT)
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024